Mitesh

Community Pharmacy England on behalf of pharmacy owners made further applications to the Department of Health and Social Care (DHSC) and the NHS Business Services Authority (NHSBSA), resulting in a further 8 new products being added to the ‘Drugs for which Discount is Not Deducted’ (DND) list from 1 January 2025. This takes the total [...]

The post 8 products added to the Discount Not Deducted (DND) list from January 2025 appeared first on Community Pharmacy England.

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (23/12/2024) announced the following final list of price concessions for December 2024: 30/12/2024: Please note this is the final list for December 2024. Drug Pack size Price concession [...]

The post December 2024 Price Concessions 4th and Final Update appeared first on Community Pharmacy England.

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (20/12/2024) announced the following list of price concessions for December 2024: Drug Pack size Price concession Alendronic acid 70mg/100ml oral solution unit dose sugar free 4 £28.78 Alfuzosin [...]

The post December 2024 Price Concessions 3rd Update appeared first on Community Pharmacy England.

Update 02/05/25 – The Department of Health and Social Care (DHSC) has provided an update on the Serious Shortage Protocols (SSPs) for Estradot® 50micrograms/24hours patches (SSP079), Estradot® 75micrograms/24hours patches (SSP080), Estradot® 100micrograms/24hours patches (SSP081) and Estradot® 25micrograms/24hours patches (SSP082).  All four SSPs were due to expire on 2 May 2025. The end date for all [...]

The post SSPs for Estradot® patches (SSP079, SSP080, SSP081and SSP082) extended appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Defect Information: Vyvgart 1000 mg solution for injection (Argenx BV) Drug alert number: EL (24)A/63 Date issued: 19 December 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Vyvgart 1000 mg solution for injection (Argenx BV) DMRC reference number: DMRC-34131563 Company name:Argenx [...]

The post MHRA Class 4 Medicines Defect Information: Vyvgart 1000 mg solution for injection (Argenx BV) appeared first on Community Pharmacy England.